secwatch.observer — SEC 8-K summary
======================================

Issuer:     89bio, Inc. (—)
CIK:        0001785173
Form:       8-K
Filed at:   2023-11-14T23:59:59+00:00
Accession:  0001193125-23-277141
Event type: other
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

89bio amends bylaws to tighten stockholder nomination rules and align with Delaware law
--------------------------------------------------------------------------------

- Enhanced procedural and disclosure requirements for stockholder director nominations and business proposals, including compliance with SEC Rule 14a-19.
- Stockholder nominating directors must represent intent to solicit proxies for non-company nominees and provide compliance evidence.
- Virtual stockholder meeting logistics clarified; requirement to open stockholder list at meetings eliminated per DGCL updates.
- Company may disregard nominations that do not meet updated requirements or fail to provide required information.
- Amendment effective November 9, 2023; board adopted Third Amended and Restated Bylaws.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1785173/000119312523277141/0001193125-23-277141-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1785173/000119312523277141/d281066d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-277141

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer